SPRB
SPRB
NASDAQ · Biotechnology

Spruce Biosciences Inc

$47.27
-0.24 (-0.51%)
As of Sep 29, 10:17 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -5.2% upside
Low Target $31.89
Average Target $44.79
High Target $48.55
Current Price $47.27
Current
$47.27
Target
$44.79
$31.89 $44.79 avg $48.55
Scenario Analysis
Bear Case
$31.89
-32.5%
Low target
Base Case
$44.79
-5.2%
Avg target
Bull Case
$48.55
+2.7%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$240.00
-80.3% from high
52-Week Low
$7.26
+551.1% from low
Target vs 52W High
$44.79
-81.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%